Clinical Trials Directory

Trials / Completed

CompletedNCT06102655

Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics

Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Shi Yun · Academic / Other
Sex
Female
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

1. Identify differential metabolites in POI patients. 2. Analysis of differential metabolites and their involved mechanism pathways.

Conditions

Interventions

TypeNameDescription
DRUGJiajian Guishen FormulationJiajian Guishen Formulation is a formulation of Traditional Chinese Medicine.POI patients will be treat with Jiajian Guishen Formulation for three menstrual cycles; their blood samples are collected before and after treatment.No drug will be used in control group, and their blood samples are collected when join the experiment.

Timeline

Start date
2023-07-24
Primary completion
2024-07-20
Completion
2024-07-20
First posted
2023-10-26
Last updated
2024-12-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06102655. Inclusion in this directory is not an endorsement.